Pharmaceutical firms face damage suit over cold remedies
Published: 2004-08-27 07:00:00
Updated: 2004-08-27 07:00:00
Recently, six Korean people filed a 500 million won damage suit against the government and some cold drug makers, claiming they had suffered side effects from medicines containing phenylpropanolamine (PPA), which allegedly cause hemorrhagic strokes.
It is the fist time Koreans have taken legal...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
